Is stem-cell bubble in a danger?

http://www.pharmatimes.com/Article/15-06-04/Novartis_turns_down_right_to_buy_Israeli_stem_cell_group.aspx

Swiss drug giant Novartis has decided not buy Israel-headquartered stem cell specialist Gamida Cell.